These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1474379)

  • 1. Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine.
    Engler RJ; Mangiafico JA; Jahrling P; Ksiazek TG; Pedrotti-Krueger M; Peters CJ
    J Med Virol; 1992 Dec; 38(4):305-10. PubMed ID: 1474379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
    Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
    Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay detection of immunoglobulins G and M to Venezuelan equine encephalomyelitis virus in vaccinated and naturally infected humans.
    Rosato RR; Macasaet FF; Jahrling PB
    J Clin Microbiol; 1988 Mar; 26(3):421-5. PubMed ID: 3356784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine.
    Pittman PR; Makuch RS; Mangiafico JA; Cannon TL; Gibbs PH; Peters CJ
    Vaccine; 1996 Mar; 14(4):337-43. PubMed ID: 8744562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus].
    Lukin EP; Chernikova NK
    Vopr Virusol; 1993; 38(2):71-4. PubMed ID: 8059525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
    Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
    Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.
    Burke DS; Ramsburg HH; Edelman R
    J Infect Dis; 1977 Sep; 136(3):354-9. PubMed ID: 903673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
    Bennett AM; Lescott T; Phillpotts RJ
    Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing antibody responses of humans and mice to vaccination with Venezuelan encephalitis (TC-83) virus.
    Fillis CA; Calisher CH
    J Clin Microbiol; 1979 Oct; 10(4):544-9. PubMed ID: 93607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host immune responses after administration of inactivated Venezuelan equine encephalomyelitis virus vaccines--III. Kinetics for neutralizing antibody immunoglobulin class responses in donors and adoptively-immunized recipients.
    Rabinowitz SG; Huprikar J; Whitacre C
    Comp Immunol Microbiol Infect Dis; 1979; 1(4):295-303. PubMed ID: 318539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83.
    Phillpotts RJ
    Vaccine; 1999 May; 17(19):2429-35. PubMed ID: 10392625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone.
    Negrette B; Bonilla E; Valero N; Giraldoth D; Medina-Leendertz S; Añez F
    Invest Clin; 2001 Dec; 42(4):235-40. PubMed ID: 11787268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of assays for the serodiagnosis of Venezuelan equine encephalitis.
    Coates DM; Makh SR; Jones N; Lloyd G
    J Infect; 1992 Nov; 25(3):279-89. PubMed ID: 1474264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
    Ferguson JA; Reeves WC; Milby MM; Hardy JL
    Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.
    Jahrling PB; Stephenson EH
    J Clin Microbiol; 1984 Mar; 19(3):429-31. PubMed ID: 6715512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
    Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
    Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru.
    Watts DM; Lavera V; Callahan J; Rossi C; Oberste MS; Roehrig JT; Cropp CB; Karabatsos N; Smith JF; Gubler DJ; Wooster MT; Nelson WM; Hayes CG
    Am J Trop Med Hyg; 1997 Jun; 56(6):661-7. PubMed ID: 9230800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
    Kinney RM; Esposito JJ; Mathews JH; Johnson BJ; Roehrig JT; Barrett AD; Trent DW
    J Virol; 1988 Dec; 62(12):4697-702. PubMed ID: 3184276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.